Effects of Transcutaneous Auricular Vagus Nerve Stimulation With Rehabilitation on the Recovery of Upper Extremity Function After Stroke: A Systematic Review and Meta-Analysis.
{"title":"Effects of Transcutaneous Auricular Vagus Nerve Stimulation With Rehabilitation on the Recovery of Upper Extremity Function After Stroke: A Systematic Review and Meta-Analysis.","authors":"Hui-Lin Li, Yan-Bing Jia, Xiao-Yan Liu, Yu-Sen Wang, Ze-Kun Zhang, Kui-Cheng Li, Xi-Zhen Wang, Jia-Xin Pan, Hao Liu","doi":"10.1155/np/9927826","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Upper limb motor dysfunction after stroke can significantly impede activities of daily living and quality of life. Transcutaneous auricular vagus nerve stimulation (taVNS) is a novel noninvasive treatment for stroke. Its combination with rehabilitation is a growing trend.</p><p><strong>Objective: </strong>To explore the effects of taVNS combined with rehabilitation on upper limb function poststroke.</p><p><strong>Methods: </strong>PubMed, EMBASE, Web of Science, EBSCO, CINAHL, and the Cochrane Library databases were searched up to September 16<sup>th</sup>, 2024. Two reviewers screened studies from these databases for eligible randomized controlled trials (RCTs) and extracted the data independently. The Cochrane collaboration tool (RoB 2.0) was used to assess the risk of bias.</p><p><strong>Results: </strong>Four studies with 129 participants were included. Compared to controls, augmented treatment with taVNS had preferable effect on improving upper limb motor function after stroke (all outcomes: standardized mean difference [SMD] = 1.28, 95% CI: 0.65-1.90, <i>I</i> <sup>2</sup> = 72%, and <i>p</i> < 0.0001; Fugl-Meyer assessment [FMA]: MD = 3.66, 95% CI: 0.50-6.83, <i>I</i> <sup>2</sup> = 90%, and <i>p</i>=0.02; Wolf Motor Function Test [WMFT]: MD = 6.77, 95% CI: -0.07 to 13.61, <i>I</i> <sup>2</sup> = 88%, and <i>p</i>=0.05)], especially combined with conventional rehabilitation (FMA: MD = 5.91, 95% CI: 1.37-10.45, <i>I</i> <sup>2</sup> = 90%, <i>p</i>=0.01). However, data from 3-month follow-up showed the similar therapeutic effects of rehabilitation with or without taVNS (FMA: MD = 4.66, 95% CI: -1.22 to 10.54, <i>I</i> <sup>2</sup> = 93%, and <i>p</i>=0.12; WMFT: MD = 6.86, 95% CI: -5.91 to 19.62, <i>I</i> <sup>2</sup> = 96%, and <i>p</i>=0.29). No obvious side effects were reported.</p><p><strong>Conclusion: </strong>This meta-analysis showed augmented effect of taVNS on rehabilitation therapy in paretic upper limb motor function poststroke, especially combined with conventional rehabilitation. However, the high heterogeneity of aggregated results indicates more rigorously designed studies are needed.</p>","PeriodicalId":19122,"journal":{"name":"Neural Plasticity","volume":"2025 ","pages":"9927826"},"PeriodicalIF":3.7000,"publicationDate":"2025-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12952199/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neural Plasticity","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/np/9927826","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Upper limb motor dysfunction after stroke can significantly impede activities of daily living and quality of life. Transcutaneous auricular vagus nerve stimulation (taVNS) is a novel noninvasive treatment for stroke. Its combination with rehabilitation is a growing trend.
Objective: To explore the effects of taVNS combined with rehabilitation on upper limb function poststroke.
Methods: PubMed, EMBASE, Web of Science, EBSCO, CINAHL, and the Cochrane Library databases were searched up to September 16th, 2024. Two reviewers screened studies from these databases for eligible randomized controlled trials (RCTs) and extracted the data independently. The Cochrane collaboration tool (RoB 2.0) was used to assess the risk of bias.
Results: Four studies with 129 participants were included. Compared to controls, augmented treatment with taVNS had preferable effect on improving upper limb motor function after stroke (all outcomes: standardized mean difference [SMD] = 1.28, 95% CI: 0.65-1.90, I2 = 72%, and p < 0.0001; Fugl-Meyer assessment [FMA]: MD = 3.66, 95% CI: 0.50-6.83, I2 = 90%, and p=0.02; Wolf Motor Function Test [WMFT]: MD = 6.77, 95% CI: -0.07 to 13.61, I2 = 88%, and p=0.05)], especially combined with conventional rehabilitation (FMA: MD = 5.91, 95% CI: 1.37-10.45, I2 = 90%, p=0.01). However, data from 3-month follow-up showed the similar therapeutic effects of rehabilitation with or without taVNS (FMA: MD = 4.66, 95% CI: -1.22 to 10.54, I2 = 93%, and p=0.12; WMFT: MD = 6.86, 95% CI: -5.91 to 19.62, I2 = 96%, and p=0.29). No obvious side effects were reported.
Conclusion: This meta-analysis showed augmented effect of taVNS on rehabilitation therapy in paretic upper limb motor function poststroke, especially combined with conventional rehabilitation. However, the high heterogeneity of aggregated results indicates more rigorously designed studies are needed.
期刊介绍：
Neural Plasticity is an international, interdisciplinary journal dedicated to the publication of articles related to all aspects of neural plasticity, with special emphasis on its functional significance as reflected in behavior and in psychopathology. Neural Plasticity publishes research and review articles from the entire range of relevant disciplines, including basic neuroscience, behavioral neuroscience, cognitive neuroscience, biological psychology, and biological psychiatry.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
